If the trials will bring real benefits, thanks to the stem cells will be possible to reconstruct an entire articular cartilage.
Will resume in the coming weeks how to start the testing of stem cells of the human brain for a possible treatment for amyotrophic lateral sclerosis. The impetus for the research, says Angelo Vescovi, Scientific Director of the Biobank of Terni, was given the authorization granted to the Biobank AIFA July 26 for the production of stem cells: “Thanks to this fact – writes bishops – in the coming weeks would resume the process of evaluating the request to proceed with a Phase 1 trial in patients with amyotrophic lateral sclerosis, which involves the transplantation of stem cells in the brain spinal cord, in the hope of at least slowing the progressive death of motor neuron cells “.
The official announcement of the resumption of research will be given tomorrow at a press conference: “Our group is already working on the development of at least two other attempts on pediatric diseases also – Bishops continues – we are developing a project that wants to expand the scope of the initiative at the international level, all in the interest of patients. ”
At this time in the world are active only two trials of the kind that could start in Italy, the researcher points out: “To this end we are working to make the Biobank of Terni a reference center of the world – he explains – which you may address all those doctors and researchers, while considering the need to rapidly proceed with new trials for neurological diseases, are unable to do so because they have neural stem cells of clinical grade available.
